Literature DB >> 24858688

MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1.

Wei Wang1, Fang Ren1, Qinghua Wu1, Dazhi Jiang1, Hongjun Li2, Zheng Peng1, Jinglu Wang1, Huirong Shi3.   

Abstract

Ovarian cancer is the leading cause of death from gynecological malignancies worldwide. Understanding the molecular mechanism underlying ovarian cancer progression facilitates the development of promising strategy for ovarian cancer therapy. Previously, we observed frequent down-regulation of miR-497 expression in ovarian cancer tissues. In this study, we investigated the role of miR-497 in ovarian cancer metastasis. We found that endogenous miR-497 expression was down-regulated in the more aggressive ovarian cancer cell lines compared with the less aggressive cells. Exogenous expression of miR-497 suppressed ovarian cancer cell migration and invasion, whereas reduction of endogenous miR-497 expression induced tumor cell migration and invasion. Mechanistic investigations confirmed pro-metastatic factor SMURF1 as a direct target of miR-497 through which miR-497 ablated tumor cell migration and invasion. Further studies revealed that lower levels of miR-497 expression were associated with shorter overall survival as well as increased SMURF1 expression in ovarian cancer patients. Our results indicate that down-regulation of miR-497 in ovarian cancer may facilitate tumor metastasis. Restoration of miR-497 expression may be a promising strategy for ovarian cancer therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Invasion; MiR-497; Migration; Ovarian cancer; Prognosis; SMURF1

Mesh:

Substances:

Year:  2014        PMID: 24858688     DOI: 10.1016/j.bbrc.2014.05.053

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  MicroRNA: master controllers of intracellular signaling pathways.

Authors:  Pak-Yin Lui; Dong-Yan Jin; Nigel J Stevenson
Journal:  Cell Mol Life Sci       Date:  2015-06-10       Impact factor: 9.261

2.  Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion.

Authors:  Xiaokun Gang; Guixia Wang; Haojie Huang
Journal:  Prostate       Date:  2015-01-28       Impact factor: 4.104

3.  MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo.

Authors:  Liang Ge; Baisong Zheng; Minghe Li; Liang Niu; Zhihong Li
Journal:  Oncol Lett       Date:  2016-01-29       Impact factor: 2.967

Review 4.  Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer.

Authors:  Rosanna H E Krakowsky; Trygve O Tollefsbol
Journal:  Front Nutr       Date:  2015-05-27

Review 5.  The Roles of MicroRNAs in Breast Cancer.

Authors:  Ryou-U Takahashi; Hiroaki Miyazaki; Takahiro Ochiya
Journal:  Cancers (Basel)       Date:  2015-04-09       Impact factor: 6.639

6.  MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.

Authors:  Juhua Zhuang; Ying Ye; Guoyu Wang; Jing Ni; Saifei He; Cuihua Hu; Wei Xia; Zhongwei Lv
Journal:  Mol Med Rep       Date:  2017-08-24       Impact factor: 3.423

7.  MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.

Authors:  Aroa Soriano; Laia París-Coderch; Luz Jubierre; Alba Martínez; Xiangyu Zhou; Olga Piskareva; Isabella Bray; Isaac Vidal; Ana Almazán-Moga; Carla Molist; Josep Roma; José R Bayascas; Oriol Casanovas; Raymond L Stallings; José Sánchez de Toledo; Soledad Gallego; Miguel F Segura
Journal:  Oncotarget       Date:  2016-02-23

8.  MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.

Authors:  Lin Wang; Cheng-fei Jiang; Dong-mei Li; Xin Ge; Zhu-mei Shi; Chong-yong Li; Xue Liu; Yu Yin; Linlin Zhen; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Oncotarget       Date:  2016-01-19

9.  MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.

Authors:  Jing-Jun Yan; Yu-Nan Zhang; Jia-Zhi Liao; Kun-peng Ke; Ying Chang; Pei-Yuan Li; Min Wang; Ju-Sheng Lin; Xing-Xing He
Journal:  Oncotarget       Date:  2015-10-06

Review 10.  miR-497 expression, function and clinical application in cancer.

Authors:  Gang Yang; Guangbing Xiong; Zhe Cao; Suli Zheng; Lei You; Taiping Zhang; Yupei Zhao
Journal:  Oncotarget       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.